First report on the safety and efficacy of an extended half-life glycoPEGylated recombinant FVIII for major surgery in severe haemophilia A

K. Hampton, P. Chowdary, S. Dunkley, S. Ehrenforth, L. Jacobsen, A. Neff, E. Santagostino, J. Sathar, H. Takedani, Clifford M Takemoto, C. Négrier

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'First report on the safety and efficacy of an extended half-life glycoPEGylated recombinant FVIII for major surgery in severe haemophilia A'. Together they form a unique fingerprint.

Medicine & Life Sciences